NCT00130611View on ClinicalTrials.gov

B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2011

Conditions
Dyspnea
Interventions
OTHER

BNP measurement

OTHER

Clinical examination

Trial Locations (9)

4000

Private Practices of Kanton Basel Stadt, Basel

4100

Private Practices of Kanton Basel-Landschaft, Basel-Landschaft

4300

Private practices of Kanton Aargau, Aarau

4500

Private practices of Kanton Solothurn, Solothurn

6060

Private practices in Kanton Obwalden, Sarnen

7500

Private Practices of Kanton Graubünden, Chur

8852

Private Practice of Kanton Schwyz, Altendorf

Unknown

Private practices of Baden-Wuertemberg, Freiburg im Breisgau

Private practices of Kanton St. Gallen, Sankt Gallen

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT00130611 - B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice | Biotech Hunter | Biotech Hunter